130 related articles for article (PubMed ID: 34697207)
1. Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to
Ip E; McNeil C; Grimison P; Scheinberg T; Tudini E; Ho G; Scott RJ; Brown C; Sandroussi C; Guitera P; Spurdle AB; Goodwin A
J Med Genet; 2022 Sep; 59(9):912-915. PubMed ID: 34697207
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.
Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J
Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
[TBL] [Abstract][Full Text] [Related]
4. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
[TBL] [Abstract][Full Text] [Related]
5. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
[TBL] [Abstract][Full Text] [Related]
6. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.
Alter BP; Rosenberg PS; Brody LC
J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431
[TBL] [Abstract][Full Text] [Related]
8. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics.
Bakker JL; Thirthagiri E; van Mil SE; Adank MA; Ikeda H; Verheul HM; Meijers-Heijboer H; de Winter JP; Sharan SK; Waisfisz Q
Hum Mutat; 2014 Apr; 35(4):442-6. PubMed ID: 24395671
[TBL] [Abstract][Full Text] [Related]
9. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
[TBL] [Abstract][Full Text] [Related]
10. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia.
Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H
Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
[TBL] [Abstract][Full Text] [Related]
14. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
[TBL] [Abstract][Full Text] [Related]
15. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
[TBL] [Abstract][Full Text] [Related]
16. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
Degrolard-Courcet E; Sokolowska J; Padeano MM; Guiu S; Bronner M; Chery C; Coron F; Lepage C; Chapusot C; Loustalot C; Jouve JL; Hatem C; Ferrant E; Martin L; Coutant C; Baurand A; Couillault G; Delignette A; El Chehadeh S; Lizard S; Arnould L; Fumoleau P; Callier P; Mugneret F; Philippe C; Frebourg T; Jonveaux P; Faivre L
Eur J Hum Genet; 2014 Aug; 22(8):979-87. PubMed ID: 24301060
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
18. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
19. Fanconi Anaemia, Childhood Cancer and the
Woodward ER; Meyer S
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680915
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
